Acadia Pharmaceuticals strengthens Nuplazid's IP, anticipates stabilization in commercial performance, and eyes future ...

We recently published a list of 10 Surprising Stocks That Skyrocketed Today. In this article, we are going to take a look at where ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) stands against other Friday ...

Post-Graduation Certification in Leadership program by Aurobindo Pharma & IMT Hyderabad for middle managers' growth." ...

A six-month programme, the CLP aims to transform promising professionals into dynamic leaders by equipping them with skills ...

Following Trump's tariff pause in April 2025, the Nifty Healthcare index rebounded strongly, rising 7%. Mutual funds ...

Hyderabad: CuraTeQ Biologics s.r.o., a wholly owned step-down subsidiary of Aurobindo Pharma Ltd, has obtained marketing ...

ACADIA Pharmaceuticals shares gained 26.5% to close at $22.26 on Friday. These analysts made changes to their price targets ...

Aurobindo’s wholly owned subsidiary, Eugia Pharma Specialities, has received the Food and Drug Administration’s permission to ...

Acadia Pharma gets favourable ruling from Delaware District Court in Nuplazid formulation patent litigation: San Diego Monday, May 19, 2025, 17:00 Hrs [IST] Acadia Pharmaceuticals ...

Acadia stock jumps 27% after winning a key patent case for Nuplazid, which will protect the drug's U.S. sales from generic erosion till 2038.